Biomarkers in CF, Canada
Objective: To identify promising novel candidate plasma and sputum biomarkers that indicate acute pulmonary exacerbations in CF. Using a non-targeted approach, we will interrogate the plasma and sputum proteome to discover novel candidate biomarkers that change in levels of expression from stable to exacerbation state. The central hypothesis of this study is that plasma and sputum biomarkers reflective of underlying disease activity can be monitored to diagnose exacerbations.
|Registered Biobank Name||Biomarkers in CF|
|Biobank Leader||Alicia Murdoch|
|Email for biobank email@example.com|
|Principal Investigator||Dr. Bradley Quon|